In SURMOUNT-2, the mean WL was up to 15.7% with tirzepatide 15 mg compared to 3.3% WL with placebo at 72 weeks for people with obesity and T2D [47]
The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s
This documentation can provide context if youre ever questioned about the contents of your bag
Sofwave is a non-invasive, FDA-cleared skin treatment that uses advanced ultrasound technology to stimulate collagen production and lift the skin
Pancreatitis Although less common, some studies have shown an increased risk of pancreatitis, an inflammation of the pancreas, in patients using GLP-1 medications
Conclusion While marketing claims suggest glp 1 patches work as a convenient shortcut, current scientific evidence continues to support physician-guided injectable GLP-1 therapy as the more reliable and biologically sound option